AZD0901
2 abstracts
Abstract
CLARITY-PanTumor01: A phase 2 trial of the claudin 18.2-specific antibody-drug conjugate AZD0901 (CMG901) in patients with CLDN18.2-expressing advanced solid tumors.Org: Global Medicines Development,
Abstract
GEMINI-Gastric: A phase 2 study of novel treatment combinations in patients with locally advanced unresectable or metastatic gastric cancers.Org: Chang Gung Memorial Hospital at Linkou and Chang Gung University, Seoul National University Graduate School, AstraZeneca Global R&D (China) Co., AstraZeneca Pharmaceutical Co.,